Wells TNC - Search Results

1

The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication.

Policastro LR, Dolci I, Godoy AS, Silva Júnior JVJ, Ruiz UEA, Santos IA, Jardim ACG, Samby K, Burrows JN, Wells TNC, Gil LHVG, Oliva G, Fernandes RS. Policastro LR, et al. Among authors: wells tnc. Viruses. 2022 Jun 21;14(7):1351. doi: 10.3390/v14071351. Viruses. 2022. PMID: 35891332 Free PMC article.

2

Open data in drug discovery and development: lessons from malaria.

Wells TN, Willis P, Burrows JN, Hooft van Huijsduijnen R. Wells TN, et al. Nat Rev Drug Discov. 2016 Oct;15(10):661-2. doi: 10.1038/nrd.2016.154. Epub 2016 Aug 12. Nat Rev Drug Discov. 2016. PMID: 27516171

3

Partnering to fight malaria in India: Past, present and future.

Samby K, Ramachandruni H, Banerji J, Burrows JN, Daumerie PG, Hooft van Huijsduijnen RAM, Duparc S, Wells TNC. Samby K, et al. Among authors: wells tnc. J Vector Borne Dis. 2019 Jan-Mar;56(1):15-24. doi: 10.4103/0972-9062.257769. J Vector Borne Dis. 2019. PMID: 31070161 Review.

4

Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.

Wells TN, Burrows JN, Baird JK. Wells TN, et al. Trends Parasitol. 2010 Mar;26(3):145-51. doi: 10.1016/j.pt.2009.12.005. Epub 2010 Feb 3. Trends Parasitol. 2010. PMID: 20133198 Review.

5

The state of the art in anti-malarial drug discovery and development.

Burrows JN, Chibale K, Wells TN. Burrows JN, et al. Curr Top Med Chem. 2011;11(10):1226-54. doi: 10.2174/156802611795429194. Curr Top Med Chem. 2011. PMID: 21401508 Review.

6

The global pipeline of new medicines for the control and elimination of malaria.

Anthony MP, Burrows JN, Duparc S, Moehrle JJ, Wells TN. Anthony MP, et al. Malar J. 2012 Sep 7;11:316. doi: 10.1186/1475-2875-11-316. Malar J. 2012. PMID: 22958514 Free PMC article. Review.

7

Designing the next generation of medicines for malaria control and eradication.

Burrows JN, van Huijsduijnen RH, Möhrle JJ, Oeuvray C, Wells TN. Burrows JN, et al. Malar J. 2013 Jun 6;12:187. doi: 10.1186/1475-2875-12-187. Malar J. 2013. PMID: 23742293 Free PMC article. Review.

8

The open access malaria box: a drug discovery catalyst for neglected diseases.

Spangenberg T, Burrows JN, Kowalczyk P, McDonald S, Wells TN, Willis P. Spangenberg T, et al. PLoS One. 2013 Jun 17;8(6):e62906. doi: 10.1371/journal.pone.0062906. Print 2013. PLoS One. 2013. PMID: 23798988 Free PMC article.

9

A High-Throughput Phenotypic Screen of the 'Pandemic Response Box' Identifies a Quinoline Derivative with Significant Anthelmintic Activity.

Shanley HT, Taki AC, Byrne JJ, Jabbar A, Wells TNC, Samby K, Boag PR, Nguyen N, Sleebs BE, Gasser RB. Shanley HT, et al. Among authors: wells tnc. Pharmaceuticals (Basel). 2022 Feb 21;15(2):257. doi: 10.3390/ph15020257. Pharmaceuticals (Basel). 2022. PMID: 35215369 Free PMC article.

10

Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro.

Jonsdottir HR, Siegrist D, Julien T, Padey B, Bouveret M, Terrier O, Pizzorno A, Huang S, Samby K, Wells TNC, Boda B, Rosa-Calatrava M, Engler OB, Constant S. Jonsdottir HR, et al. Among authors: wells tnc. Biomed Pharmacother. 2022 Jun;150:113058. doi: 10.1016/j.biopha.2022.113058. Epub 2022 May 2. Biomed Pharmacother. 2022. PMID: 35658229 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

223 results

Search Page